Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Arthritis; Arthritis, Rheumatoid | Phase 3 | ClinicalTrials |
| Autoimmune Diseases | Phase 2 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 4 | ClinicalTrials |
| Arthritis; Arthritis, Juvenile | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Juvenile | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 4 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 2 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Juvenile | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Juvenile | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 3 | ClinicalTrials |
| Arthritis; Arthritis, Juvenile | Phase 3 | ClinicalTrials |
CONTENTS